fda approval tirzepatide is approved for obesity Breaking News: Approves Treating FDA Approves Diabetes Drug Tirzepatide – RxConnection | FDA Approves New

We're giving you 90 days' notice to figure out what you want to do.'" From 2025 to 2026, 12 million people were on plans that dropped coverage for Zepbound and 12 million had plans that dropped Wegovy, another GLP-1, according to research by GoodRx, a website that helps patients find discounts on prescription drugs

This is especially helpful if your insurance plan does not cover weight-loss treatments

The TrufaMED program separates them

Obesity or increased weight can be caused by a variety of factors, such as genetics, lifestyle choices, or underlying health conditions

Frequently Asked Questions About Orforglipron vs Semaglutide: Oral GLP-1 Small Molecule vs Proven Peptide Which is better, Orforglipron or Semaglutide

Pickart L, Thaler M